Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |